Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, code, cloud, nicecloud)
 

'en:phosvitin'
(id=7186930 ; fe=en:phosvitin ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1868 creation date=2017-06-26 touchdate=2025-12-06 00:25:13.000)
≈ 56 relations sortantes

  1. en:phosvitin -- r_associated #0: 39 / 1 -> en:conalbumin
    n1=en:phosvitin | n2=en:conalbumin | rel=r_associated | relid=0 | w=39
  2. en:phosvitin -- r_associated #0: 36 / 0.923 -> chimie
    n1=en:phosvitin | n2=chimie | rel=r_associated | relid=0 | w=36
  3. en:phosvitin -- r_associated #0: 35 / 0.897 -> en:aspects of adverse effects
    n1=en:phosvitin | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=35
  4. en:phosvitin -- r_associated #0: 35 / 0.897 -> en:breast cancer type 1 susceptibility protein
    n1=en:phosvitin | n2=en:breast cancer type 1 susceptibility protein | rel=r_associated | relid=0 | w=35
  5. en:phosvitin -- r_associated #0: 35 / 0.897 -> en:cellular tumor antigen p53
    n1=en:phosvitin | n2=en:cellular tumor antigen p53 | rel=r_associated | relid=0 | w=35
  6. en:phosvitin -- r_associated #0: 35 / 0.897 -> en:interferon regulatory factor-7
    n1=en:phosvitin | n2=en:interferon regulatory factor-7 | rel=r_associated | relid=0 | w=35
  7. en:phosvitin -- r_associated #0: 35 / 0.897 -> en:vitellins
    n1=en:phosvitin | n2=en:vitellins | rel=r_associated | relid=0 | w=35
  8. en:phosvitin -- r_associated #0: 34 / 0.872 -> en:focal adhesion kinase 1
    n1=en:phosvitin | n2=en:focal adhesion kinase 1 | rel=r_associated | relid=0 | w=34
  9. en:phosvitin -- r_associated #0: 34 / 0.872 -> en:lamin
    n1=en:phosvitin | n2=en:lamin | rel=r_associated | relid=0 | w=34
  10. en:phosvitin -- r_associated #0: 34 / 0.872 -> en:ovalbumin
    n1=en:phosvitin | n2=en:ovalbumin | rel=r_associated | relid=0 | w=34
  11. en:phosvitin -- r_associated #0: 34 / 0.872 -> en:ovomucin
    n1=en:phosvitin | n2=en:ovomucin | rel=r_associated | relid=0 | w=34
  12. en:phosvitin -- r_associated #0: 34 / 0.872 -> en:phosphoprotein
    n1=en:phosvitin | n2=en:phosphoprotein | rel=r_associated | relid=0 | w=34
  13. en:phosvitin -- r_associated #0: 34 / 0.872 -> en:retinoblastoma-associated protein
    n1=en:phosvitin | n2=en:retinoblastoma-associated protein | rel=r_associated | relid=0 | w=34
  14. en:phosvitin -- r_associated #0: 34 / 0.872 -> en:smad proteins, receptor-regulated
    n1=en:phosvitin | n2=en:smad proteins, receptor-regulated | rel=r_associated | relid=0 | w=34
  15. en:phosvitin -- r_associated #0: 34 / 0.872 -> en:zyxin
    n1=en:phosvitin | n2=en:zyxin | rel=r_associated | relid=0 | w=34
  16. en:phosvitin -- r_associated #0: 32 / 0.821 -> en:bioformation
    n1=en:phosvitin | n2=en:bioformation | rel=r_associated | relid=0 | w=32
  17. en:phosvitin -- r_associated #0: 32 / 0.821 -> en:dephosphosvitin
    n1=en:phosvitin | n2=en:dephosphosvitin | rel=r_associated | relid=0 | w=32
  18. en:phosvitin -- r_associated #0: 32 / 0.821 -> en:egg proteins, dietary
    n1=en:phosvitin | n2=en:egg proteins, dietary | rel=r_associated | relid=0 | w=32
  19. en:phosvitin -- r_associated #0: 32 / 0.821 -> en:stathmin
    n1=en:phosvitin | n2=en:stathmin | rel=r_associated | relid=0 | w=32
  20. en:phosvitin -- r_associated #0: 31 / 0.795 -> en:chemical aspects
    n1=en:phosvitin | n2=en:chemical aspects | rel=r_associated | relid=0 | w=31
  21. en:phosvitin -- r_associated #0: 31 / 0.795 -> en:cyclin-dependent kinase 1
    n1=en:phosvitin | n2=en:cyclin-dependent kinase 1 | rel=r_associated | relid=0 | w=31
  22. en:phosvitin -- r_associated #0: 30 / 0.769 -> en:crk-associated substrate protein
    n1=en:phosvitin | n2=en:crk-associated substrate protein | rel=r_associated | relid=0 | w=30
  23. en:phosvitin -- r_associated #0: 30 / 0.769 -> en:fanconi anemia group d2 protein
    n1=en:phosvitin | n2=en:fanconi anemia group d2 protein | rel=r_associated | relid=0 | w=30
  24. en:phosvitin -- r_associated #0: 30 / 0.769 -> en:retinoblastoma-like protein 1
    n1=en:phosvitin | n2=en:retinoblastoma-like protein 1 | rel=r_associated | relid=0 | w=30
  25. en:phosvitin -- r_associated #0: 30 / 0.769 -> en:retinoblastoma-like protein p130
    n1=en:phosvitin | n2=en:retinoblastoma-like protein p130 | rel=r_associated | relid=0 | w=30
  26. en:phosvitin -- r_associated #0: 29 / 0.744 -> en:casein
    n1=en:phosvitin | n2=en:casein | rel=r_associated | relid=0 | w=29
  27. en:phosvitin -- r_associated #0: 29 / 0.744 -> en:deficiency aspects
    n1=en:phosvitin | n2=en:deficiency aspects | rel=r_associated | relid=0 | w=29
  28. en:phosvitin -- r_associated #0: 29 / 0.744 -> en:paxillin
    n1=en:phosvitin | n2=en:paxillin | rel=r_associated | relid=0 | w=29
  29. en:phosvitin -- r_associated #0: 28 / 0.718 -> en:analysis aspect
    n1=en:phosvitin | n2=en:analysis aspect | rel=r_associated | relid=0 | w=28
  30. en:phosvitin -- r_associated #0: 28 / 0.718 -> en:caveolin-1
    n1=en:phosvitin | n2=en:caveolin-1 | rel=r_associated | relid=0 | w=28
  31. en:phosvitin -- r_associated #0: 28 / 0.718 -> en:cortactin
    n1=en:phosvitin | n2=en:cortactin | rel=r_associated | relid=0 | w=28
  32. en:phosvitin -- r_associated #0: 28 / 0.718 -> en:standards characteristics
    n1=en:phosvitin | n2=en:standards characteristics | rel=r_associated | relid=0 | w=28
  33. en:phosvitin -- r_associated #0: 28 / 0.718 -> phosvitine
    n1=en:phosvitin | n2=phosvitine | rel=r_associated | relid=0 | w=28
  34. en:phosvitin -- r_associated #0: 27 / 0.692 -> en:fanconi anemia group a protein
    n1=en:phosvitin | n2=en:fanconi anemia group a protein | rel=r_associated | relid=0 | w=27
  35. en:phosvitin -- r_associated #0: 26 / 0.667 -> en:contraindications aspect
    n1=en:phosvitin | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=26
  36. en:phosvitin -- r_associated #0: 26 / 0.667 -> en:drug effect
    n1=en:phosvitin | n2=en:drug effect | rel=r_associated | relid=0 | w=26
  37. en:phosvitin -- r_associated #0: 26 / 0.667 -> en:methylmercaptovitin
    n1=en:phosvitin | n2=en:methylmercaptovitin | rel=r_associated | relid=0 | w=26
  38. en:phosvitin -- r_associated #0: 26 / 0.667 -> en:pharmacokinetic aspects
    n1=en:phosvitin | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=26
  39. en:phosvitin -- r_associated #0: 26 / 0.667 -> en:vitellogenins
    n1=en:phosvitin | n2=en:vitellogenins | rel=r_associated | relid=0 | w=26
  40. en:phosvitin -- r_associated #0: 25 / 0.641 -> en:agonists
    n1=en:phosvitin | n2=en:agonists | rel=r_associated | relid=0 | w=25
  41. en:phosvitin -- r_associated #0: 25 / 0.641 -> en:interferon regulatory factor 3
    n1=en:phosvitin | n2=en:interferon regulatory factor 3 | rel=r_associated | relid=0 | w=25
  42. en:phosvitin -- r_associated #0: 25 / 0.641 -> en:therapeutic use - qualifier
    n1=en:phosvitin | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=25
  43. en:phosvitin -- r_associated #0: 25 / 0.641 -> phosphosérine aminotransférase (déficit en)
    n1=en:phosvitin | n2=phosphosérine aminotransférase (déficit en) | rel=r_associated | relid=0 | w=25
  44. en:phosvitin -- r_associated #0: 24 / 0.615 -> en:mechanism of action qualifier
    n1=en:phosvitin | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=24
  45. en:phosvitin -- r_associated #0: 23 / 0.59 -> en:physiological aspects
    n1=en:phosvitin | n2=en:physiological aspects | rel=r_associated | relid=0 | w=23
  46. en:phosvitin -- r_associated #0: 21 / 0.538 -> en:fanconi anemia complementation group g protein
    n1=en:phosvitin | n2=en:fanconi anemia complementation group g protein | rel=r_associated | relid=0 | w=21
  47. en:phosvitin -- r_associated #0: 20 / 0.513 -> conalbumine
    n1=en:phosvitin | n2=conalbumine | rel=r_associated | relid=0 | w=20
  48. en:phosvitin -- r_associated #0: 20 / 0.513 -> effet d'un médicament
    n1=en:phosvitin | n2=effet d'un médicament | rel=r_associated | relid=0 | w=20
  49. en:phosvitin -- r_associated #0: 20 / 0.513 -> en:bcl2 antagonist of cell death
    n1=en:phosvitin | n2=en:bcl2 antagonist of cell death | rel=r_associated | relid=0 | w=20
  50. en:phosvitin -- r_associated #0: 20 / 0.513 -> en:caveolin 2
    n1=en:phosvitin | n2=en:caveolin 2 | rel=r_associated | relid=0 | w=20
  51. en:phosvitin -- r_associated #0: 20 / 0.513 -> en:dopamine and camp-regulated phosphoprotein 32
    n1=en:phosvitin | n2=en:dopamine and camp-regulated phosphoprotein 32 | rel=r_associated | relid=0 | w=20
  52. en:phosvitin -- r_associated #0: 20 / 0.513 -> en:egg proteins
    n1=en:phosvitin | n2=en:egg proteins | rel=r_associated | relid=0 | w=20
  53. en:phosvitin -- r_associated #0: 20 / 0.513 -> en:zona pellucida glycoproteins
    n1=en:phosvitin | n2=en:zona pellucida glycoproteins | rel=r_associated | relid=0 | w=20
  54. en:phosvitin -- r_associated #0: 20 / 0.513 -> ovotransferrine
    n1=en:phosvitin | n2=ovotransferrine | rel=r_associated | relid=0 | w=20
  55. en:phosvitin -- r_associated #0: 20 / 0.513 -> vitellins
    n1=en:phosvitin | n2=vitellins | rel=r_associated | relid=0 | w=20
  56. en:phosvitin -- r_associated #0: 2 / 0.051 -> en:amino acid, peptide, or protein
    n1=en:phosvitin | n2=en:amino acid, peptide, or protein | rel=r_associated | relid=0 | w=2
≈ 62 relations entrantes

  1. conalbumine --- r_associated #0: 92 --> en:phosvitin
    n1=conalbumine | n2=en:phosvitin | rel=r_associated | relid=0 | w=92
  2. en:conalbumin --- r_associated #0: 90 --> en:phosvitin
    n1=en:conalbumin | n2=en:phosvitin | rel=r_associated | relid=0 | w=90
  3. ovotransferrine --- r_associated #0: 85 --> en:phosvitin
    n1=ovotransferrine | n2=en:phosvitin | rel=r_associated | relid=0 | w=85
  4. effet d'un médicament --- r_associated #0: 51 --> en:phosvitin
    n1=effet d'un médicament | n2=en:phosvitin | rel=r_associated | relid=0 | w=51
  5. en:drug effect --- r_associated #0: 47 --> en:phosvitin
    n1=en:drug effect | n2=en:phosvitin | rel=r_associated | relid=0 | w=47
  6. en:egg proteins --- r_associated #0: 39 --> en:phosvitin
    n1=en:egg proteins | n2=en:phosvitin | rel=r_associated | relid=0 | w=39
  7. en:bioformation --- r_associated #0: 37 --> en:phosvitin
    n1=en:bioformation | n2=en:phosvitin | rel=r_associated | relid=0 | w=37
  8. en:deficiency aspects --- r_associated #0: 36 --> en:phosvitin
    n1=en:deficiency aspects | n2=en:phosvitin | rel=r_associated | relid=0 | w=36
  9. en:bcl2 antagonist of cell death --- r_associated #0: 35 --> en:phosvitin
    n1=en:bcl2 antagonist of cell death | n2=en:phosvitin | rel=r_associated | relid=0 | w=35
  10. en:breast cancer type 1 susceptibility protein --- r_associated #0: 35 --> en:phosvitin
    n1=en:breast cancer type 1 susceptibility protein | n2=en:phosvitin | rel=r_associated | relid=0 | w=35
  11. en:egg proteins, dietary --- r_associated #0: 35 --> en:phosvitin
    n1=en:egg proteins, dietary | n2=en:phosvitin | rel=r_associated | relid=0 | w=35
  12. en:physiological aspects --- r_associated #0: 34 --> en:phosvitin
    n1=en:physiological aspects | n2=en:phosvitin | rel=r_associated | relid=0 | w=34
  13. en:smad proteins, receptor-regulated --- r_associated #0: 34 --> en:phosvitin
    n1=en:smad proteins, receptor-regulated | n2=en:phosvitin | rel=r_associated | relid=0 | w=34
  14. en:therapeutic use - qualifier --- r_associated #0: 34 --> en:phosvitin
    n1=en:therapeutic use - qualifier | n2=en:phosvitin | rel=r_associated | relid=0 | w=34
  15. en:vitellogenins --- r_associated #0: 34 --> en:phosvitin
    n1=en:vitellogenins | n2=en:phosvitin | rel=r_associated | relid=0 | w=34
  16. en:zona pellucida glycoproteins --- r_associated #0: 34 --> en:phosvitin
    n1=en:zona pellucida glycoproteins | n2=en:phosvitin | rel=r_associated | relid=0 | w=34
  17. phosvitine --- r_associated #0: 34 --> en:phosvitin
    n1=phosvitine | n2=en:phosvitin | rel=r_associated | relid=0 | w=34
  18. en:standards characteristics --- r_associated #0: 31 --> en:phosvitin
    n1=en:standards characteristics | n2=en:phosvitin | rel=r_associated | relid=0 | w=31
  19. en:caveolin 2 --- r_associated #0: 30 --> en:phosvitin
    n1=en:caveolin 2 | n2=en:phosvitin | rel=r_associated | relid=0 | w=30
  20. en:fanconi anemia group a protein --- r_associated #0: 30 --> en:phosvitin
    n1=en:fanconi anemia group a protein | n2=en:phosvitin | rel=r_associated | relid=0 | w=30
  21. en:cortactin --- r_associated #0: 29 --> en:phosvitin
    n1=en:cortactin | n2=en:phosvitin | rel=r_associated | relid=0 | w=29
  22. en:crk-associated substrate protein --- r_associated #0: 29 --> en:phosvitin
    n1=en:crk-associated substrate protein | n2=en:phosvitin | rel=r_associated | relid=0 | w=29
  23. en:fanconi anemia complementation group g protein --- r_associated #0: 29 --> en:phosvitin
    n1=en:fanconi anemia complementation group g protein | n2=en:phosvitin | rel=r_associated | relid=0 | w=29
  24. en:fanconi anemia group d2 protein --- r_associated #0: 29 --> en:phosvitin
    n1=en:fanconi anemia group d2 protein | n2=en:phosvitin | rel=r_associated | relid=0 | w=29
  25. en:interferon regulatory factor 3 --- r_associated #0: 29 --> en:phosvitin
    n1=en:interferon regulatory factor 3 | n2=en:phosvitin | rel=r_associated | relid=0 | w=29
  26. en:mechanism of action qualifier --- r_associated #0: 29 --> en:phosvitin
    n1=en:mechanism of action qualifier | n2=en:phosvitin | rel=r_associated | relid=0 | w=29
  27. en:pharmacokinetic aspects --- r_associated #0: 29 --> en:phosvitin
    n1=en:pharmacokinetic aspects | n2=en:phosvitin | rel=r_associated | relid=0 | w=29
  28. en:agonists --- r_associated #0: 28 --> en:phosvitin
    n1=en:agonists | n2=en:phosvitin | rel=r_associated | relid=0 | w=28
  29. en:interferon regulatory factor-7 --- r_associated #0: 28 --> en:phosvitin
    n1=en:interferon regulatory factor-7 | n2=en:phosvitin | rel=r_associated | relid=0 | w=28
  30. en:cyclin-dependent kinase 1 --- r_associated #0: 27 --> en:phosvitin
    n1=en:cyclin-dependent kinase 1 | n2=en:phosvitin | rel=r_associated | relid=0 | w=27
  31. en:dopamine and camp-regulated phosphoprotein 32 --- r_associated #0: 27 --> en:phosvitin
    n1=en:dopamine and camp-regulated phosphoprotein 32 | n2=en:phosvitin | rel=r_associated | relid=0 | w=27
  32. en:retinoblastoma-like protein 1 --- r_associated #0: 26 --> en:phosvitin
    n1=en:retinoblastoma-like protein 1 | n2=en:phosvitin | rel=r_associated | relid=0 | w=26
  33. en:retinoblastoma-like protein p130 --- r_associated #0: 26 --> en:phosvitin
    n1=en:retinoblastoma-like protein p130 | n2=en:phosvitin | rel=r_associated | relid=0 | w=26
  34. en:vitellins --- r_associated #0: 26 --> en:phosvitin
    n1=en:vitellins | n2=en:phosvitin | rel=r_associated | relid=0 | w=26
  35. vitellins --- r_associated #0: 26 --> en:phosvitin
    n1=vitellins | n2=en:phosvitin | rel=r_associated | relid=0 | w=26
  36. cycline B/cdk1 --- r_associated #0: 23 --> en:phosvitin
    n1=cycline B/cdk1 | n2=en:phosvitin | rel=r_associated | relid=0 | w=23
  37. chimie --- r_associated #0: 20 --> en:phosvitin
    n1=chimie | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  38. en:analysis aspect --- r_associated #0: 20 --> en:phosvitin
    n1=en:analysis aspect | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  39. en:aspects of adverse effects --- r_associated #0: 20 --> en:phosvitin
    n1=en:aspects of adverse effects | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  40. en:casein --- r_associated #0: 20 --> en:phosvitin
    n1=en:casein | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  41. en:caveolin-1 --- r_associated #0: 20 --> en:phosvitin
    n1=en:caveolin-1 | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  42. en:cellular tumor antigen p53 --- r_associated #0: 20 --> en:phosvitin
    n1=en:cellular tumor antigen p53 | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  43. en:chemical aspects --- r_associated #0: 20 --> en:phosvitin
    n1=en:chemical aspects | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  44. en:contraindications aspect --- r_associated #0: 20 --> en:phosvitin
    n1=en:contraindications aspect | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  45. en:dephosphosvitin --- r_associated #0: 20 --> en:phosvitin
    n1=en:dephosphosvitin | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  46. en:focal adhesion kinase 1 --- r_associated #0: 20 --> en:phosvitin
    n1=en:focal adhesion kinase 1 | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  47. en:lamin --- r_associated #0: 20 --> en:phosvitin
    n1=en:lamin | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  48. en:methylmercaptovitin --- r_associated #0: 20 --> en:phosvitin
    n1=en:methylmercaptovitin | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  49. en:ovalbumin --- r_associated #0: 20 --> en:phosvitin
    n1=en:ovalbumin | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  50. en:ovomucin --- r_associated #0: 20 --> en:phosvitin
    n1=en:ovomucin | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  51. en:paxillin --- r_associated #0: 20 --> en:phosvitin
    n1=en:paxillin | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  52. en:phosphoprotein --- r_associated #0: 20 --> en:phosvitin
    n1=en:phosphoprotein | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  53. en:retinoblastoma-associated protein --- r_associated #0: 20 --> en:phosvitin
    n1=en:retinoblastoma-associated protein | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  54. en:stathmin --- r_associated #0: 20 --> en:phosvitin
    n1=en:stathmin | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  55. en:zyxin --- r_associated #0: 20 --> en:phosvitin
    n1=en:zyxin | n2=en:phosvitin | rel=r_associated | relid=0 | w=20
  56. en:cyclinB/Cdkl --- r_associated #0: 10 --> en:phosvitin
    n1=en:cyclinB/Cdkl | n2=en:phosvitin | rel=r_associated | relid=0 | w=10
  57. focal adhesion kinase 1 --- r_associated #0: 10 --> en:phosvitin
    n1=focal adhesion kinase 1 | n2=en:phosvitin | rel=r_associated | relid=0 | w=10
  58. ovalbumine --- r_associated #0: 10 --> en:phosvitin
    n1=ovalbumine | n2=en:phosvitin | rel=r_associated | relid=0 | w=10
  59. ovomucine --- r_associated #0: 10 --> en:phosvitin
    n1=ovomucine | n2=en:phosvitin | rel=r_associated | relid=0 | w=10
  60. phosphoproteine --- r_associated #0: 10 --> en:phosvitin
    n1=phosphoproteine | n2=en:phosvitin | rel=r_associated | relid=0 | w=10
  61. phosphosérine aminotransférase (déficit en) --- r_associated #0: 10 --> en:phosvitin
    n1=phosphosérine aminotransférase (déficit en) | n2=en:phosvitin | rel=r_associated | relid=0 | w=10
  62. stathmine --- r_associated #0: 10 --> en:phosvitin
    n1=stathmine | n2=en:phosvitin | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr